These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 25373077)

  • 41. The relationship between bispectral index and propofol during target-controlled infusion anesthesia: a comparative study between children and young adults.
    Rigouzzo A; Girault L; Louvet N; Servin F; De-Smet T; Piat V; Seeman R; Murat I; Constant I
    Anesth Analg; 2008 Apr; 106(4):1109-16, table of contents. PubMed ID: 18349180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An evaluation of using population pharmacokinetic models to estimate pharmacodynamic parameters for propofol and bispectral index in children.
    Coppens MJ; Eleveld DJ; Proost JH; Marks LA; Van Bocxlaer JF; Vereecke H; Absalom AR; Struys MM
    Anesthesiology; 2011 Jul; 115(1):83-93. PubMed ID: 21555936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of administration rate on propofol plasma-effect site equilibration.
    Struys MM; Coppens MJ; De Neve N; Mortier EP; Doufas AG; Van Bocxlaer JF; Shafer SL
    Anesthesiology; 2007 Sep; 107(3):386-96. PubMed ID: 17721240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive pharmacokinetic and pharmacodynamic modelling to predict propofol effect using BIS-guided anesthesia.
    Martín-Mateos I; Méndez Pérez JA; Reboso Morales JA; Gómez-González JF
    Comput Biol Med; 2016 Aug; 75():173-80. PubMed ID: 27294779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous regulation of hemodynamic and anesthetic states: a simulation study.
    Rao RR; Bequette BW; Roy RJ
    Ann Biomed Eng; 2000 Jan; 28(1):71-84. PubMed ID: 10645790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and pharmacodynamic concepts underpinning total intravenous anesthesia.
    Schnider TW
    J Cardiothorac Vasc Anesth; 2015 Jun; 29 Suppl 1():S7-S10. PubMed ID: 26025045
    [No Abstract]   [Full Text] [Related]  

  • 47. Multi-model generalised predictive control for intravenous anaesthesia under inter-individual variability.
    Jing CJ; Syafiie S
    J Clin Monit Comput; 2021 Oct; 35(5):1037-1045. PubMed ID: 32833146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal adaptive control of drug dosing using integral reinforcement learning.
    Padmanabhan R; Meskin N; Haddad WM
    Math Biosci; 2019 Mar; 309():131-142. PubMed ID: 30735696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anaesthesia for thyroplasty.
    George A
    Anaesthesia; 1999 May; 54(5):493-4. PubMed ID: 10995151
    [No Abstract]   [Full Text] [Related]  

  • 50. Basic pharmacokinetic principles for intravenous anaesthesia.
    Engbers F
    Adv Exp Med Biol; 2003; 523():3-18. PubMed ID: 15088835
    [No Abstract]   [Full Text] [Related]  

  • 51. Administration to humans of ORG 21465, a water soluble steroid i.v. anaesthetic agent.
    Sneyd JR; Wright PM; Cross M; Thompson P; Voortman G; Weideman MM; Andrews CJ; Daniell CJ
    Br J Anaesth; 1997 Oct; 79(4):427-32. PubMed ID: 9389257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of depth of anaesthesia using fractional-order adaptive high-gain controller.
    Boroujerdi Alavi M; Tabatabaei M
    IET Syst Biol; 2019 Feb; 13(1):36-42. PubMed ID: 30774115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Fast Parameter Identification Framework for Personalized Pharmacokinetics.
    Yang C; Tavassolian N; Haddad WM; Bailey JM; Gholami B
    Sci Rep; 2019 Oct; 9(1):14143. PubMed ID: 31578414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypnosis regulation in propofol anaesthesia employing super-twisting sliding mode control to compensate variability dynamics.
    Ilyas M; Iqbal J; Ahmad S; Uppal AA; Imtiaz WA; Riaz RA
    IET Syst Biol; 2020 Apr; 14(2):59-67. PubMed ID: 32196464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous infusion techniques: how to do it and why we should do it.
    Glass PS
    Can J Anaesth; 1998 May; 45(5 Pt 2):R117-37. PubMed ID: 9599682
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical application of pharmacokinetic and pharmacodynamic models.
    Billard V
    Adv Exp Med Biol; 2003; 523():57-70. PubMed ID: 15088840
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetic-pharmacodynamic population modelling in paediatric anaesthesia and its clinical translation.
    Morse JD; Hannam J; Anderson BJ
    Curr Opin Anaesthesiol; 2019 Jun; 32(3):353-362. PubMed ID: 31045640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergency anaesthesia in central core disease.
    Georgiou AP; Gatward J
    Br J Anaesth; 2008 Apr; 100(4):567. PubMed ID: 18344580
    [No Abstract]   [Full Text] [Related]  

  • 59. Changes in EF during induction of anaesthesia with two different iv techniques.
    Muralidhar K; Gopinath R
    Acta Anaesthesiol Scand; 1991 Jan; 35(1):91-2. PubMed ID: 2006607
    [No Abstract]   [Full Text] [Related]  

  • 60. Control strategy with multivariable fault tolerance module for automatic intravenous anesthesia.
    Patel B; Patel H; Shah D; Sarvaia A
    Biomed Eng Lett; 2020 Nov; 10(4):555-578. PubMed ID: 33194248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.